Neurocrine Biosciences Statistics
Total Valuation
NBIX has a market cap or net worth of $16.40 billion. The enterprise value is $15.55 billion.
| Market Cap | 16.40B |
| Enterprise Value | 15.55B |
Important Dates
The last earnings date was Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NBIX has 100.55 million shares outstanding. The number of shares has decreased by -0.68% in one year.
| Current Share Class | 100.55M |
| Shares Outstanding | 100.55M |
| Shares Change (YoY) | -0.68% |
| Shares Change (QoQ) | -0.29% |
| Owned by Insiders (%) | 1.18% |
| Owned by Institutions (%) | 102.51% |
| Float | 99.29M |
Valuation Ratios
The trailing PE ratio is 25.09 and the forward PE ratio is 14.59. NBIX's PEG ratio is 0.34.
| PE Ratio | 25.09 |
| Forward PE | 14.59 |
| PS Ratio | 5.29 |
| Forward PS | 4.11 |
| PB Ratio | 4.82 |
| P/TBV Ratio | 4.81 |
| P/FCF Ratio | 19.73 |
| P/OCF Ratio | 18.99 |
| PEG Ratio | 0.34 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.77, with an EV/FCF ratio of 18.70.
| EV / Earnings | 23.26 |
| EV / Sales | 5.01 |
| EV / EBITDA | 18.77 |
| EV / EBIT | 19.47 |
| EV / FCF | 18.70 |
Financial Position
The company has a current ratio of 2.93, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.93 |
| Quick Ratio | 2.51 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.52 |
| Debt / FCF | 0.56 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 22.50% and return on invested capital (ROIC) is 23.74%.
| Return on Equity (ROE) | 22.50% |
| Return on Assets (ROA) | 11.62% |
| Return on Invested Capital (ROIC) | 23.74% |
| Return on Capital Employed (ROCE) | 19.60% |
| Weighted Average Cost of Capital (WACC) | 6.25% |
| Revenue Per Employee | $1.55M |
| Profits Per Employee | $334,300 |
| Employee Count | 2,000 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 17.89 |
Taxes
In the past 12 months, NBIX has paid $268.90 million in taxes.
| Income Tax | 268.90M |
| Effective Tax Rate | 28.68% |
Stock Price Statistics
The stock price has increased by +30.09% in the last 52 weeks. The beta is 0.40, so NBIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +30.09% |
| 50-Day Moving Average | 142.90 |
| 200-Day Moving Average | 140.38 |
| Relative Strength Index (RSI) | 63.54 |
| Average Volume (20 Days) | 1,208,856 |
Short Selling Information
The latest short interest is 5.16 million, so 5.13% of the outstanding shares have been sold short.
| Short Interest | 5.16M |
| Short Previous Month | 5.99M |
| Short % of Shares Out | 5.13% |
| Short % of Float | 5.20% |
| Short Ratio (days to cover) | 4.00 |
Income Statement
In the last 12 months, NBIX had revenue of $3.10 billion and earned $668.60 million in profits. Earnings per share was $6.50.
| Revenue | 3.10B |
| Gross Profit | 2.00B |
| Operating Income | 798.80M |
| Pretax Income | 937.50M |
| Net Income | 668.60M |
| EBITDA | 828.60M |
| EBIT | 798.80M |
| Earnings Per Share (EPS) | $6.50 |
Balance Sheet
The company has $1.32 billion in cash and $463.50 million in debt, with a net cash position of $852.70 million or $8.48 per share.
| Cash & Cash Equivalents | 1.32B |
| Total Debt | 463.50M |
| Net Cash | 852.70M |
| Net Cash Per Share | $8.48 |
| Equity (Book Value) | 3.41B |
| Book Value Per Share | 33.87 |
| Working Capital | 1.60B |
Cash Flow
In the last 12 months, operating cash flow was $863.70 million and capital expenditures -$32.40 million, giving a free cash flow of $831.30 million.
| Operating Cash Flow | 863.70M |
| Capital Expenditures | -32.40M |
| Depreciation & Amortization | 29.80M |
| Net Borrowing | n/a |
| Free Cash Flow | 831.30M |
| FCF Per Share | $8.27 |
Margins
Gross margin is 64.37%, with operating and profit margins of 25.75% and 21.55%.
| Gross Margin | 64.37% |
| Operating Margin | 25.75% |
| Pretax Margin | 30.22% |
| Profit Margin | 21.55% |
| EBITDA Margin | 26.71% |
| EBIT Margin | 25.75% |
| FCF Margin | 26.80% |
Dividends & Yields
NBIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.68% |
| Shareholder Yield | 0.68% |
| Earnings Yield | 4.08% |
| FCF Yield | 5.07% |
Analyst Forecast
The average price target for NBIX is $192.88, which is 18.24% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $192.88 |
| Price Target Difference | 18.24% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 29 |
| Revenue Growth Forecast (3Y) | 20.77% |
| EPS Growth Forecast (3Y) | 36.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NBIX has an Altman Z-Score of 6.99 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.99 |
| Piotroski F-Score | 6 |